| 2024/07/16 17:13:45 | |
|---|---|
| Price | |
| 0.0001 EUR | |
| Difference | 0.00% (0.00) |
General attributes
| ISIN | BE0003846632 |
| Symbol | OXUR |
| Exchange | Euronext Brussels |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 1 EUR |
| Benchmark | BEL 20 INDEX |
Market data
| Bid (Bid size) | - |
| Ask (Ask size) | - (54,559,680) |
| Open | 0.0001 EUR |
| High | 0.0001 EUR |
| Low | 0.0001 EUR |
| Close (prev. day) | 0.0001 EUR |
| VWAP | 0.0001 EUR |
| Volume (pcs) | 25,911,552 |
| Trading volume | 2,591.00 |
| Number of trades | 32 |
| Last size | 152,552 |
Futures and Options
| Related Futures | - |
| Related Options | - |
PDF Downloads
| Company report: OXURION N.V. |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/07/12 |
|
Global Equity Ratings |
|
| 2024/06/21 |
|
Global Equity Ratings |
|
| 2024/06/14 |
|
Global Equity Ratings |
|
| 2024/05/29 |
|
Global Equity Ratings |
|
| 2024/04/26 |
|
Global Equity Ratings |
|
| 2024/07/16 17:13:45 | |
|---|---|
| Price | |
| 0.0001 EUR | |
| Difference | 0.00% (0.00) |
General attributes
| ISIN | BE0003846632 |
| Symbol | OXUR |
| Exchange | Euronext Brussels |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 1 EUR |
| Benchmark | BEL 20 INDEX |
Market data
| Bid (Bid size) | - |
| Ask (Ask size) | - (54,559,680) |
| Open | 0.0001 EUR |
| High | 0.0001 EUR |
| Low | 0.0001 EUR |
| Close (prev. day) | 0.0001 EUR |
| VWAP | 0.0001 EUR |
| Volume (pcs) | 25,911,552 |
| Trading volume | 2,591.00 |
| Number of trades | 32 |
| Last size | 152,552 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | -75.00% | -94.74% | -100.00% |
| Perf (abs.) | +0.00 | +0.00 | -2.43 |
| Beta | -2.61 | -0.76 | 0.19 |
| Volatility | 485.46 | 383.35 | 264.23 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 0.0001 EUR (145,614,361) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 0.0001 EUR (74,514,690) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 0.0001 EUR (110,005,264) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 0.0007 EUR (70,755,826) |
| YTD High | date | 0.0006 EUR (2024/01/02) |
| YTD Low | date | 0.0001 EUR (2024/03/07) |
| 52 Weeks High | date | 0.0049 EUR (2023/08/04) |
| 52 Weeks Low | date | 0.0001 EUR (2024/03/07) |
All listings for OXURION N.V.
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Stuttgart | 2024/07/16 | 08:02 | 0.0001 EUR | 0.00 | 1 |
| London Stock Exchange | 2020/10/06 | 17:36 | 2.56 EUR | 0.21 | 1 |
| Frankfurt | 2024/07/16 | 21:50 | 0.0001 EUR | 0.00 | 2 |
| Euronext Brussels | 2024/07/16 | 17:13 | 0.0001 EUR | 0.00 | 32 |
| Berlin | 2024/07/16 | 08:12 | 0.0001 EUR | 0.00 | 1 |
Company Logo
Contact Details
| OXURION NV |
| - - |
| Gaston Geenslaan 1, Heverlee - 3001 Leuven |
| Telefon: +32-1-675-13-10 |
| Fax: + |
| E-mail: info@oxurion.com |
PDF Downloads
| Company report: OXURION N.V. | |
Company Profile
Oxurion NV is a biopharmaceutical company, which engages in developing and commercializing medicines for the treatment of vitreo retinal diseases. It operates under JETREA brand name. The company was founded by Desire Collen in 1991 and is headquartered in Leuven, Belgium. |
Members of Management Board
| Tom Graney | Chairman of Managing Board |
| Andy De Deene | Member of Executive Committee |
| Kathleen Paisley | Member of Executive Committee |
| Michael Dillen | Member of Executive Committee |
Board of directors
| Charles Paris de Bollardire | Chairman of Supervisory Board |
| Anat Loewenstein | Member of Supervisory Board |
| James Hartmann | Member of Supervisory Board |
| Nathalie Laarakker | Member of Supervisory Board |